Mr. Speaker, if there has been anyone who could be described as the most transparent during this entire process, it is certainly our Prime Minister of Canada, who has set up a series of procedures to account to the House for what has gone on.
With respect to the Earnscliffe contracts, they were contracts given by Industry Canada to a firm qualified as an expert since 1998, that works with the research team for the Canadian Biotechnology Secretariat, and that is an expert in the field, to support all biotechnology activities in the country. This was done in accordance with all the rules approved by the Treasury Board.